PTPN13 and non-small cell lung carcinoma: Furthermore, fibroblast activating protein 1 (FAP-1), a marker of fibroblast activation, and a significant marker enabling to distinguish CAFs, is proposed as a biomarker for NSCLC prognosis [13].